作者：
Bredeson,C. [1]
;
LeRademacher,J. [2]
;
Kato,K. [3]
;
DiPersio,J.F. [4]
;
Agura,E. [5]
;
Devine,S.M. [6]
;
Appelbaum,F.R. [7]
;
Tomblyn,M.R. [8]
;
Laport,G.G. [9]
;
Zhu,X. [10]
;
McCarthy,P.L. [11]
;
Ho,V.T. [12]
;
Cooke,K.R. ;
Armstrong,E. ;
Smith,A. ;
Rizzo,J.D. ;
Burkart,J.M. ;
Pasquini,M.C.
作者单位：
Siteman Cancer Center, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis
[1]
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
[2]
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States
[3]
Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, United States
[4]
Baylor University Medical Center, Dallas, TX, United States
[5]
Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA
[6]
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin
[7]
Pediatric BMT Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School
[8]
Roswell Park Cancer Institute, Buffalo, NY, United States
[9]
James Cancer Center, Ohio State University Medical Center, Columbus, OH, United States
[10]
University of Ottawa at the Ottawa Hospital Research Institute, Ottawa, ON, Canada
[11]
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[12]
发布时间
2018-07-27
换一批
